These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 394866

  • 1. Nitrosoureas: a reappraisal of clinical trials.
    Katz ME, Glick JH.
    Cancer Clin Trials; 1979; 2(4):297-316. PubMed ID: 394866
    [Abstract] [Full Text] [Related]

  • 2. The nitrosoureas: carmustine (BCNU) and lomustine (CCNU).
    Weiss RB, Issell BF.
    Cancer Treat Rev; 1982 Dec; 9(4):313-30. PubMed ID: 6762924
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Nitrosourea combinations in lung cancer.
    Livingston RB.
    Cancer Treat Rep; 1976 Jun; 60(6):757-760. PubMed ID: 182365
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical comparison of the nitrosoureas.
    Wasserman TH, Slavik M, Carter SK.
    Cancer; 1975 Oct; 36(4):1258-68. PubMed ID: 1100221
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Role of a nitrosourea (CCNU, NSC-79037) in advanced nonhematologic cancer.
    Perloff M, Muggia FM, Ackerman C.
    Cancer Chemother Rep; 1974 Oct; 58(3):421-4. PubMed ID: 4841718
    [No Abstract] [Full Text] [Related]

  • 11. Contributions of nitrosoureas to cancer treatment.
    Mitchell EP, Schein PS.
    Cancer Treat Rep; 1986 Jan; 70(1):31-41. PubMed ID: 3002621
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Recent updates in the clinical use of platinum compounds for the treatment of lung, breast, and genitourinary tumors and myeloma.
    Belani CP.
    Semin Oncol; 2004 Dec; 31(6 Suppl 14):25-33. PubMed ID: 15726531
    [Abstract] [Full Text] [Related]

  • 14. Therapeutic potentiation of nitrosoureas using chlorpromazine and caffeine in the treatment of murine tumors.
    Rose WC, Trader MW, Dykes DJ, Laster WR, Schabel FM.
    Cancer Treat Rep; 1978 Dec; 62(12):2085-93. PubMed ID: 751716
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Nitrosoureas in multiple myeloma.
    Salmon SE.
    Cancer Treat Rep; 1976 Jun; 60(6):789-94. PubMed ID: 782701
    [Abstract] [Full Text] [Related]

  • 17. Methyl-CCNU inclinical cancer therapy.
    Wasserman TH, Slavik M, Carter SK.
    Cancer Treat Rev; 1974 Dec; 1(4):251-69. PubMed ID: 4377543
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Biologic activity of MCNU: a new antitumor agent.
    Sekido S, Ninomiya K, Iwasaki M.
    Cancer Treat Rep; 1979 Jun; 63(6):961-70. PubMed ID: 466655
    [Abstract] [Full Text] [Related]

  • 20. Nitrosourea combination chemotherapy: 1-(2-chloroethyl)-3-(4-methyl cyclohexyl)-1-nitrosourea (methyl-CCNU) and cyclophosphamide.
    Lokich JJ, Skarin AT.
    Oncology; 1975 Jun; 32(3-4):169-74. PubMed ID: 768852
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.